BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 281 filers reported holding BLUEBIRD BIO INC in Q2 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,198,000 | +6.1% | 100,000 | 0.0% | 0.90% | +12.0% |
| Q1 2021 | $3,015,000 | -13.7% | 100,000 | +23.8% | 0.81% | +11.6% |
| Q4 2020 | $3,494,000 | -19.8% | 80,744 | 0.0% | 0.72% | +98.6% |
| Q3 2020 | $4,356,000 | -11.6% | 80,744 | 0.0% | 0.36% | -58.3% |
| Q2 2020 | $4,929,000 | +79.5% | 80,744 | +35.1% | 0.87% | +227.8% |
| Q1 2020 | $2,746,000 | – | 59,744 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |